Literature DB >> 7963647

Type VII collagen specifically binds fibronectin via a unique subdomain within the collagenous triple helix.

J C Lapiere1, J D Chen, T Iwasaki, L Hu, J Uitto, D T Woodley.   

Abstract

Type VII collagen is the major component of anchoring fibrils, structures within basement membranes beneath stratified squamous epithelium thought to mediate the adherence of the epidermis to the dermis of human skin. Type VII collagen has affinity for fibronectin. The interaction between type VII collagen and fibronectin is mediated through the collagen-binding domain on the amino terminus of fibronectin. Heretofore, the domain on the type VII collagen molecule that binds to fibronectin was not known. In this study, we mapped the binding site of fibronectin to a specific subdomain of the triple helical collagenous region of type VII collagen, immediately adjacent to the small carboxyl terminal non-collagenous domain. This fibronectin-binding site within the type VII collagen molecule lies between nucleotide residues 615 and 1161.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7963647     DOI: 10.1111/1523-1747.ep12398270

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

Review 1.  Epidermolysis bullosa acquisita.

Authors:  Rishu Gupta; David T Woodley; Mei Chen
Journal:  Clin Dermatol       Date:  2012 Jan-Feb       Impact factor: 3.541

Review 2.  Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen.

Authors:  Mei Chen; Gene H Kim; Lori Prakash; David T Woodley
Journal:  Autoimmunity       Date:  2011-09-28       Impact factor: 2.815

3.  Cross-linking of the dermo-epidermal junction of skin regenerating from keratinocyte autografts. Anchoring fibrils are a target for tissue transglutaminase.

Authors:  M Raghunath; B Höpfner; D Aeschlimann; U Lüthi; M Meuli; S Altermatt; R Gobet; L Bruckner-Tuderman; B Steinmann
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

4.  Characterization of molecular mechanisms underlying mutations in dystrophic epidermolysis bullosa using site-directed mutagenesis.

Authors:  David T Woodley; Yingping Hou; Sabrina Martin; Wei Li; Mei Chen
Journal:  J Biol Chem       Date:  2008-04-30       Impact factor: 5.157

5.  The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita.

Authors:  Mei Chen; Arvin Doostan; Pubali Bandyopadhyay; Jennifer Remington; Xinyi Wang; Yingping Hou; Ziu Liu; David T Woodley
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

Review 6.  Autoimmunity to type VII collagen: epidermolysis bullosa acquisita.

Authors:  David T Woodley; Jennifer Remington; Mei Chen
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

7.  Transcriptome and ultrastructural changes in dystrophic Epidermolysis bullosa resemble skin aging.

Authors:  Jenny S Breitenbach; Mark Rinnerthaler; Andrea Trost; Manuela Weber; Alfred Klausegger; Christina Gruber; Daniela Bruckner; Herbert A Reitsamer; Johann W Bauer; Michael Breitenbach
Journal:  Aging (Albany NY)       Date:  2015-06       Impact factor: 5.682

8.  An RNA-targeted therapy for dystrophic epidermolysis bullosa.

Authors:  Patricia Peking; Ulrich Koller; Blanca Duarte; Rodolfo Murillas; Susanne Wolf; Tobias Maetzig; Michael Rothe; Thomas Kocher; Marta García; Gabriele Brachtl; Axel Schambach; Fernando Larcher; Julia Reichelt; Johann W Bauer; Eva M Murauer
Journal:  Nucleic Acids Res       Date:  2017-09-29       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.